AI Imaging Edge Target hospitals and surgical centers performing spinal needle interventions and musculoskeletal trauma care with AI-first ultrasound visualization. Promote BoneEnhance segmentation and CADe/x fracture detection to improve visualization, decision speed, and patient safety. Leverage Rivanna's FDA-registered facility and ISO 13485 certification to support procurement discussions and reduce regulatory friction for new deployments.

Military and VA Capitalize on the military-optimized ultrasound guidance initiative and government grant activity to pursue contracts with defense health facilities and Veterans Affairs hospitals. Propose pilots and training programs around spinal intervention workflows, ensuring alignment with care processes and interoperability with existing ultrasound platforms.

Strategic Partnerships Engage anaesthesiologists, CRNAs, and health systems that routinely perform ultrasound-guided procedures to drive adoption of BoneVision, BoneEnhance, and SpineNav3D. Explore co-development, integration partnerships with ultrasound vendors or clinical service providers, and training programs to shorten time-to-value.

Regulatory Advantage Highlight the FDA-registered manufacturing facility and ISO 13485 certification as key evidence of quality and regulatory readiness to accelerate procurement. Offer pre-market readiness support and clear post-market monitoring to help customers meet compliance requirements across regions.

Proof of Value Leverage industry recognition, finalist placements, and scale-up awards to build credibility and reduce buyer risk. Use early clinical results and case studies to demonstrate ROI in terms of increased procedure success, shorter procedure times, and lower complication rates, accelerating conversations with hospitals and payers.